BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1481903)

  • 1. Myocardial performance of STZ-diabetic DOCA-hypertensive rats.
    Dai S; McNeill JH
    Am J Physiol; 1992 Dec; 263(6 Pt 2):H1798-805. PubMed ID: 1481903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated cardiovascular function in the conscious streptozotocin-diabetic deoxycorticosterone-acetate-hypertensive rats.
    Schenk J; Hebden RA; Dai S; McNeill JH
    Pharmacology; 1994 Apr; 48(4):211-5. PubMed ID: 8177907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative evaluation of different rat models with co-existing diabetes-mellitus and hypertension.
    Hakim ZS; Goyal RK
    Indian J Physiol Pharmacol; 2000 Apr; 44(2):125-35. PubMed ID: 10846625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of deoxycorticosterone acetate on glucose metabolism in nondiabetic and streptozotocin-diabetic rats.
    Dai S; Fraser H; McNeill JH
    Can J Physiol Pharmacol; 1992 Nov; 70(11):1468-72. PubMed ID: 1296859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of long-term treatment with enalapril in streptozotocin diabetic and DOCA hypertensive rats.
    Goyal RK; Satia MC; Bangaru RA; Gandhi TP
    J Cardiovasc Pharmacol; 1998 Aug; 32(2):317-22. PubMed ID: 9700996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic treatment with lisinopril on cardiovascular complications in streptozotocin diabetic and DOCA hypertensive rats.
    Sevak AR; Goyal RK
    Pharmacol Res; 1996; 34(5-6):201-9. PubMed ID: 9076844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of DOCA hypertension with induction of atherosclerosis in rats with short-term diabetes mellitus.
    Hebden RA; Todd ME; Tang C; Gowen B; McNeill JH
    Am J Physiol; 1990 Apr; 258(4 Pt 2):R1042-50. PubMed ID: 2331024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in diastolic function and collagen content in normotensive and hypertensive rats with long-term streptozotocin-induced diabetes.
    Riva E; Andreoni G; Bianchi R; Latini R; Luvarà G; Jeremic G; Traquandi C; Tuccinardi L
    Pharmacol Res; 1998 Mar; 37(3):233-40. PubMed ID: 9602473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. meta-iodobenzylguanidine uptake in the hypertensive-diabetic rat heart: a marker for myocardial dysfunction?
    Herman LM; Dai S; Hartman NG; McNeill JH
    Can J Physiol Pharmacol; 1994 Oct; 72(10):1162-7. PubMed ID: 7882180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of fructose loading in streptozotocin-diabetic and nondiabetic rats.
    Dai S; McNeill JH
    Can J Physiol Pharmacol; 1992 Dec; 70(12):1583-9. PubMed ID: 1301236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuated cardioprotective response to bradykinin, but not classical ischaemic preconditioning, in DOCA-salt hypertensive left ventricular hypertrophy.
    Ebrahim Z; Yellon DM; Baxter GF
    Pharmacol Res; 2007 Jan; 55(1):42-8. PubMed ID: 17079163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of simultaneous diabetes and hypertension in an insulin dependent diabetic model.
    Mozaffari MS; Jirakulsomchok S; Wyss JM
    Int J Exp Pathol; 1991 Dec; 72(6):655-64. PubMed ID: 1768611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypothalamic responsiveness in DOCA hypertensive rats augmented by streptozotocin-induced diabetes.
    Sasaki S; Buñag RD
    J Cardiovasc Pharmacol; 1982; 4(6):1042-8. PubMed ID: 6185770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of chronic treatment with amlodipine in streptozotocin-diabetic and spontaneously hypertensive rats.
    Srinivasan PS; Hakim ZS; Santani DD; Goyal RK
    Pharmacol Res; 1997 May; 35(5):423-8. PubMed ID: 9299205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of clonidine in streptozotocin-induced diabetes and DOCA-hypertensive rats.
    Satia MC; Damani RR; Goyal RK
    J Pharm Pharmacol; 1997 Oct; 49(10):1030-5. PubMed ID: 9364415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hypertension on the development of diabetic cardiomyopathy.
    Mathis DR; Liu SS; Rodrigues BB; McNeill JH
    Can J Physiol Pharmacol; 2000 Oct; 78(10):791-8. PubMed ID: 11077979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in cardiac function in streptozotocin-diabetic rats by salt loading.
    Dai S; Fraser H; Yuen VG; McNeill JH
    Can J Physiol Pharmacol; 1994 Nov; 72(11):1288-93. PubMed ID: 7767868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of probucol on impaired cardiac performance and lipid metabolism in streptozotocin-induced diabetic rats.
    Tada H; Oida K; Kutsumi Y; Shimada Y; Nakai T; Miyabo S
    J Cardiovasc Pharmacol; 1992 Aug; 20(2):179-86. PubMed ID: 1381008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myocardial performance in conscious streptozotocin diabetic rats.
    Borges GR; de Oliveira M; Salgado HC; Fazan R
    Cardiovasc Diabetol; 2006 Dec; 5():26. PubMed ID: 17144912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of contractile function in diabetic hypertensive cardiomyopathy in adult rat ventricular myocytes.
    Wold LE; Relling DP; Colligan PB; Scott GI; Hintz KK; Ren BH; Epstein PN; Ren J
    J Mol Cell Cardiol; 2001 Sep; 33(9):1719-26. PubMed ID: 11549350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.